Baxter International Inc. Share Price Berne S.E.
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.11 CHF | +3.50% | -.--% | -.--% |
Sales 2024 * | 15.11B 13.81B 1,190B | Sales 2025 * | 15.66B 14.31B 1,233B | Capitalization | 17.5B 16B 1,378B |
---|---|---|---|---|---|
Net income 2024 * | 703M 643M 55.36B | Net income 2025 * | 950M 868M 74.81B | EV / Sales 2024 * | 1.8 x |
Net Debt 2024 * | 9.7B 8.87B 764B | Net Debt 2025 * | 8.8B 8.04B 693B | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
18.5
x | P/E ratio 2025 * |
15.2
x | Employees | - |
Yield 2024 * |
3.51% | Yield 2025 * |
3.64% | Free-Float | 74.27% |
Latest transcript on Baxter International Inc.
1 day | +3.50% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 30/09/15 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 17/10/23 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 05/02/17 |
Peter Wilver
BRD | Director/Board Member | 64 | 09/05/22 |
Director/Board Member | 64 | 17/02/19 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.31% | 182B | |
-1.21% | 114B | |
-5.53% | 67.76B | |
+1.22% | 51.91B | |
+7.03% | 43.23B | |
+6.07% | 41.07B | |
+21.96% | 32.07B | |
+15.86% | 25B | |
-4.81% | 24.55B |
- Stock Market
- Equities
- BAX Stock
- BAX Stock